Skip to main content
. 2021 Jan 27;4(1):e2034750. doi: 10.1001/jamanetworkopen.2020.34750

Figure 1. Treatment Response and Prednisone Dose Among 41 Patients with Steroid-Refractory Chronic Graft-vs-Host Disease (cGVHD).

Figure 1.

Median (range) treatment duration was 8.6 (1.1-24.9) months in responders. CR indicates complete remission; GI, gastrointestinal tract; PD, progressive disease; PR, partial remission; and SD, stable disease.